CD24 and ovarian cancer: Rüdiger Klapdor designed a novel third-generation CAR-NK targeting CD24 for the treatment of ovarian cancer, and they selected a single-chain variable fragment (scFv) in SWA11 mAb to be placed on the third-generation CAR backbone.